» Articles » PMID: 10049066

The Type of Stromal Feeder Used in Limiting Dilution Assays Influences Frequency and Maintenance Assessment of Human Long-term Culture Initiating Cells

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 1999 Feb 12
PMID 10049066
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this study was to evaluate if differences in culture conditions used in long-term culture assays affect enumeration of LTC-IC in freshly sorted or ex vivo expanded CD34+/HLA-DRdim/CD2-/CD7- (34+/Lin-) cells. The variables examined included different stromal feeders (murine bone marrow fibroblast cell line, M2-10B4 and murine fetal liver cell line, AFT024) and presence or absence of cytokines (MIP-1alpha + IL-3). The absolute LTC-IC frequency in 34+/Lin- cells measured in limiting dilution assays (LDA) on AFT024 (4.45 +/- 0.69%) was significantly higher than in M2-10B4 (1.45 +/- 0.20%) LDA. Addition of MIP-1alpha and IL-3 to AFT024 LDA increased the measured LTC-IC frequency to 6.8 +/- 0.9%. We also determined the fraction of LTC-IC that persisted after 34+/Lin cells were cultured for 5 weeks by replating progeny in the three LDA readout systems. The measured LTC-IC maintenance was significantly lower when M2-10B4 LDA (13.1 +/- 3.5%, P < 0.05) were used compared with AFT024 LDA (36.6 +/- 5.5%) or AFT024 LDA supplemented with MIP-1alpha and IL-3 (29.1 +/- 6.3%). Thus, the number of LTC-IC measured in freshly sorted 34+ cells depends on the stromal feeder used in LDA assays. Furthermore, and most important, assessment of LTC-IC expansion or maintenance may vary significantly depending on the type of stromal feeder used to enumerate LTC-IC.

Citing Articles

From stem cell to immune effector: how adhesion, migration, and polarity shape T-cell and natural killer cell lymphocyte development in vitro and in vivo.

Lee B, Mace E Mol Biol Cell. 2020; 31(10):981-991.

PMID: 32352896 PMC: 7346728. DOI: 10.1091/mbc.E19-08-0424.


Functional assessment of hematopoietic niche cells derived from human embryonic stem cells.

Ferrell P, Hexum M, Kopher R, Lepley M, Gussiaas A, Kaufman D Stem Cells Dev. 2014; 23(12):1355-63.

PMID: 24517837 PMC: 4046207. DOI: 10.1089/scd.2013.0497.


In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry.

Nichols J, Cortiella J, Lee J, Niles J, Cuddihy M, Wang S Biomaterials. 2008; 30(6):1071-9.

PMID: 19042018 PMC: 2650812. DOI: 10.1016/j.biomaterials.2008.10.041.


Isolation and therapeutic potential of human haemopoietic stem cells.

Clark A, Jorgensen H, Mountford J, Holyoake T Cytotechnology. 2008; 41(2-3):111-31.

PMID: 19002948 PMC: 3466700. DOI: 10.1023/A:1024822722285.


Hematopoietic progenitor cells and interleukin-stimulated endothelium: expansion and differentiation of myeloid precursors.

Moldenhauer A, Genter G, Lun A, Bal G, Kiesewetter H, Salama A BMC Immunol. 2008; 9:56.

PMID: 18826654 PMC: 2570655. DOI: 10.1186/1471-2172-9-56.